Day 1 - Monday, 28 October 2019
Meeting category
Date(s)
28 Oct 2019 - 29 Oct 2019
Location
Tokyo,
Japan
Organizer
Tokyo Hepatitis Clinical Forum 2019
Related Enduring Materials
Enduring Materials
Session 1 -
Chairs
Kazuhiko Koike, MD, PhD
University of Tokyo, Japan
Charles Boucher, MD
Erasmus Medical Center, the Netherlands
Epidemological trends in viral Hepatitis B and C in Japan (No permission to publish slides)
Junko Tanaka, MD, PhD
Hiroshima University, Japan
Trend of NAFLD/ NASH in Japan (No video available)
Trends in epidemiology of hepatitis B and HCC in Asia (No video available)
Sang Hoon Ahn, MD, PhD
Yonsei University College of Medicine, South Korea
Session 2: Clinical management of Hepatitis C -
Mark Nelson, MA, MBBS, FRCP
Chair
Tesuo Takehara
-
Man-Fung Yuen, DSc, MD, PhD
University of Hong Kong, Hong Kong
State-of-the-Art: Current clinical management of hepatitis C in Japan (No permission to publish slides or video)
Nobuyuki Enomoto, MD, PhD
University of Yamanashi, Japan
Hepatitis C management in special populations
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
HCV-associated HCC - Basics and clinics (No permission to publish slides or video)
Naoya Kato, MD, PhD
Chiba University, Japan
Session 3: Clinical management of Hepatitis B -
Chair
Naoya Kato, MD, PhD
Chiba University, Japan
Naoya Sakamoto, MD
Hokkaido University, Japan
State-of-the-Art: Current clinical management of hepatitis in Japan (No permission to publish slides or video)
Hiroshi Yatsuhashi, MD
NHO Nagasaki Medical Center, Japan
Management of Hepatitis B reactivation (No video available)
Co-infection of HIV, HBV and HCV (No permission to publish slides or video)
Hiroyuki Gatanaga, MD, PhD
National Center For Global Health And Medicine, Japan
New anti-HBV drugs in the pipeline (No video available)
Day 2 - Tuesday, 29 October 2019
Session 4 -
Session 4: Hepatitis C elimination strategies
Nobuyuki Enomoto, MD, PhD
University of Yamanashi, Japan
Peter Revill, MD, PhD
Victorian Infectious Diseases Reference Laboratory, Australia
Update on Hepatitis C elimination strategies (No permission to publish slides)
Current treatment of decompensated cirrhosis (No permission to publish slides or video)
Tetsuo Takehara, MD
Osaka University, Japan
Session 5: Future clinical management of liver diseases -
Chairs
Yasuhito Tanaka, MD, PhD
Nagoya City University, Japan
Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Burnet Institute, Australia
Current and future treamtments of NASH (No permission to publish slides or video)
Atsushi Nakajima, MD
Yokohama City University, Japan
Closure of the conference
Overview
Welcome
We would like to thank everyone that joined the Tokyo HEP Clinical Forum 2019 in Tokyo, Japan.
We experienced excellent discussions and lectures during this meeting.
On behalf of the Program Chairs we would like to thank our conference supporter Gilead Sciences for their unrestricted generous support and all of the endorsers.
The presentation materials have been made available here on this website.
We would like to encourage you and your colleagues to plan submission of your upcoming research results to the next edition of this meeting.
Background
The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts/research programs.
Program Chairs
Support
Support
Language
Related Programs
